Open Medicine
(Jan 2022)
Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?
Herczeg Gyorgy,
Somogyi Aniko,
Herold Magdolna,
Fodor Agnes,
Rosta Klara,
Dank Magdolna,
Lang Zsolt,
Herold Zoltan
Affiliations
Herczeg Gyorgy
Department of General Surgery, Szent Imre University Teaching Hospital, Budapest, Hungary
Somogyi Aniko
Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary
Herold Magdolna
Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary
Fodor Agnes
Department of General Surgery, Szent Imre University Teaching Hospital, Budapest, Hungary
Rosta Klara
Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
Dank Magdolna
Department of Internal Medicine and Oncology, Division of Oncology, Semmelweis University, Budapest, Hungary
Lang Zsolt
Department of Biomathematics and Informatics, University of Veterinary Medicine Budapest, Budapest, Hungary
Herold Zoltan
Department of Internal Medicine and Haematology, Semmelweis University, Szentkiralyi utca 46., H-1088 Budapest, Hungary
DOI
https://doi.org/10.1515/med-2021-0407
Journal volume & issue
Vol. 17,
no. 1
Abstract
Read online
A large variety of factors can affect colorectal cancer (CRC) survival, including type 2 diabetes mellitus (T2DM) and paraneoplastic thrombocytosis. Although several common factors play a role in their development and platelets are damaged in both diseases, the combined relationship of the three conditions was never investigated previously.
Keywords
WeChat QR code
Close
